Key result
Botulinum toxin review outlines clinical and cosmetic applications without reporting outcome data.
Answers are grounded in this paper and cite their sources.
Botulinum toxin is in the news these days. First came September 11 and fears of chemical terrorism. One gram of this “most poisonous poison” could kill a million people were it not for problems of delivery. Then, in April 2002, the Food and Drug Administration (FDA) approved the use of botulinum toxin for the treatment of “frown lines” at the glabella, between and above the eyes. This cosmetic use of the toxin has already attracted the interest of countless people who want to look younger. The toxin is also used to erase “crow's feet” — wrinkles at the lateral margin . . .
No takes yet. Share an insight, caveat, or question.
Lewis P. Rowland (2002) conducted an editorial in Stroke and spasticity. Botulinum toxin was evaluated. Botulinum toxin is discussed regarding its clinical and cosmetic applications, though no clinical trial outcomes are reported in this excerpt.
Synapse has enriched 10 related papers. Consider them for comparative context: